Search research articles
Contact Us
Filters
Showing results (101-110 of 154) with videos related to
Page
of 16
Sort By:
Clinical Medicine & Research
|
September 1, 2018
Abdominal Physical Signs and Medical Eponyms: Physical Examination of Palpation Part 1, 1876-1907
Vaibhav Rastogi, Devina Singh, Halil Tekiner, et al.
Clinical Therapeutics
|
January 1, 1994
Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis
M Prevost, Y Turenne, D W Moote, et al.
Cancer
|
January 15, 1993
A VM 26-based regimen for patients with previously untreated non-Hodgkin lymphoma. Prolonged disease-free survival in patients younger than 60 years of age: a phase II trial of the eastern Cooperative Oncology Group
L I Gordon, J Andersen, S Gregory, et al.
Wisconsin Medical Journal
|
December 1, 1983
Improved treatment of acute nonlymphocytic leukemia in a community hospital--The Marshfield Clinic/St Joseph's Hospital; experience 1974-1981
J P Conterato, W R Friedenberg, J J Mazza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1984
Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly
S B Kahn, C B Begg, J J Mazza, et al.
Comprehensive Therapy
|
March 29, 2005
Disorders of flushing
Steven H Yale, Shikha Vasudeva, Joseph J Mazza, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin
|
November 3, 2017
Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine
Christopher Bray, Lauren N Bell, Hong Liang, et al.
The Journal of School Health
|
November 1, 2005
Do social and behavioral characteristics targeted by preventive interventions predict standardized test scores and grades?
Charles B Fleming, Kevin P Haggerty, Richard F Catalano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1984
High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia
J D Hines, M M Oken, J J Mazza, et al.
Clinical Medicine & Research
|
June 6, 2014
Reinitiating warfarin: relationships between dose and selected patient, clinical and hospital measures
Lucas G Leonhard, Richard L Berg, James K Burmester, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 154) with videos related to
Sort By:
Page
of 16
Clinical Medicine & Research
|
September 1, 2018
Abdominal Physical Signs and Medical Eponyms: Physical Examination of Palpation Part 1, 1876-1907
Vaibhav Rastogi, Devina Singh, Halil Tekiner, et al.
Clinical Therapeutics
|
January 1, 1994
Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis
M Prevost, Y Turenne, D W Moote, et al.
Cancer
|
January 15, 1993
A VM 26-based regimen for patients with previously untreated non-Hodgkin lymphoma. Prolonged disease-free survival in patients younger than 60 years of age: a phase II trial of the eastern Cooperative Oncology Group
L I Gordon, J Andersen, S Gregory, et al.
Wisconsin Medical Journal
|
December 1, 1983
Improved treatment of acute nonlymphocytic leukemia in a community hospital--The Marshfield Clinic/St Joseph's Hospital; experience 1974-1981
J P Conterato, W R Friedenberg, J J Mazza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1984
Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly
S B Kahn, C B Begg, J J Mazza, et al.
Comprehensive Therapy
|
March 29, 2005
Disorders of flushing
Steven H Yale, Shikha Vasudeva, Joseph J Mazza, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin
|
November 3, 2017
Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine
Christopher Bray, Lauren N Bell, Hong Liang, et al.
The Journal of School Health
|
November 1, 2005
Do social and behavioral characteristics targeted by preventive interventions predict standardized test scores and grades?
Charles B Fleming, Kevin P Haggerty, Richard F Catalano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1984
High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia
J D Hines, M M Oken, J J Mazza, et al.
Clinical Medicine & Research
|
June 6, 2014
Reinitiating warfarin: relationships between dose and selected patient, clinical and hospital measures
Lucas G Leonhard, Richard L Berg, James K Burmester, et al.
Page
of 16